The Spring 2013 issue of tagline contains three articles about TB research:
1) on rifapentine research and access,
2) on adaptive clinical trial designs, and
3) on pediatric drug development needs.
The full newsletter is available here: http://www.treatmentactiongroup.org/tagline/2013/spring